Citation: F. Cainelli et al., Mortality due to hepatitis C virus-related cirrhosis in patients infected with HIV type 1: A role for alcohol, CLIN INF D, 33(10), 2001, pp. 1795-1796
Authors:
Quaglio, G
Lugoboni, F
Vento, S
Lechi, A
Accordini, A
Bossi, C
Faccini, M
Mecenero, V
Pani, A
Pantalena, M
Residori, M
Mezzelani, P
Citation: G. Quaglio et al., Isolated presence of antibody to hepatitis B core antigen in injection drug users: Do they need to be vaccinated?, CLIN INF D, 32(10), 2001, pp. E143-E144
Authors:
Longhi, MS
Cainelli, F
Concia, E
Vento, S
Citation: Ms. Longhi et al., No increase in liver decompensation risk with atypical hepatitis C virus antibody pattern, J INFEC DIS, 183(9), 2001, pp. 1428-1428
Authors:
Cainelli, F
Longhi, MS
Concia, E
Vento, S
Citation: F. Cainelli et al., Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B, AM J GASTRO, 96(5), 2001, pp. 1651-1652
Authors:
Luzzati, R
Amalfitano, G
Lazzarini, L
Soldani, F
Bellino, S
Solbiati, M
Danzi, MC
Vento, S
Todeschini, G
Vivenza, C
Concia, E
Citation: R. Luzzati et al., Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital, EUR J CL M, 19(8), 2000, pp. 602-607
Authors:
Saaristo, A
Partanen, TA
Arola, J
Jussila, L
Hytonen, M
Makitie, A
Vento, S
Kaipainen, A
Malmberg, H
Alitalo, K
Citation: A. Saaristo et al., Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasalmucosa and in nasopharyngeal tumors, AM J PATH, 157(1), 2000, pp. 7-14
Authors:
Di Perri, G
Vento, S
Mazzi, R
Bonora, S
Bonora, A
Trevenzoli, M
Allegranzi, B
Carretta, G
Lanzafame, M
Pizzighella, S
Concia, E
Citation: G. Di Perri et al., Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy, J INFECTION, 39(3), 1999, pp. 193-197
Authors:
Lanzafame, M
Trevenzoli, M
Carretta, G
Lazzarini, L
Vento, S
Concia, E
Citation: M. Lanzafame et al., Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy, CHEST, 116(3), 1999, pp. 848-849